Molecular epigenetics in the management of ovarian cancer: are we investigating a rational clinical promise?
about
Lysophosphatidic Acid Mediates Activating Transcription Factor 3 Expression Which Is a Target for Post-Transcriptional Silencing by miR-30c-2-3p.The HDACi Panobinostat Shows Growth Inhibition Both In Vitro and in a Bioluminescent Orthotopic Surgical Xenograft Model of Ovarian Cancer.Clinical impact of circulating microRNAs as blood-based marker in childhood acute lymphoblastic leukemia.C/EBPβ enhances platinum resistance of ovarian cancer cells by reprogramming H3K79 methylation.Endometriosis Malignant Transformation: Epigenetics as a Probable Mechanism in Ovarian Tumorigenesis.
P2860
Molecular epigenetics in the management of ovarian cancer: are we investigating a rational clinical promise?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 April 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Molecular epigenetics in the m ...... g a rational clinical promise?
@en
Molecular epigenetics in the m ...... g a rational clinical promise?
@nl
type
label
Molecular epigenetics in the m ...... g a rational clinical promise?
@en
Molecular epigenetics in the m ...... g a rational clinical promise?
@nl
prefLabel
Molecular epigenetics in the m ...... g a rational clinical promise?
@en
Molecular epigenetics in the m ...... g a rational clinical promise?
@nl
P2093
P2860
P356
P1476
Molecular epigenetics in the m ...... g a rational clinical promise?
@en
P2093
Ha T Nguyen
Mandi M Murph
P2860
P356
10.3389/FONC.2014.00071
P577
2014-04-08T00:00:00Z